223 related articles for article (PubMed ID: 12486188)
1. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice.
Berrendero F; Kieffer BL; Maldonado R
J Neurosci; 2002 Dec; 22(24):10935-40. PubMed ID: 12486188
[TBL] [Abstract][Full Text] [Related]
2. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene.
Berrendero F; Mendizábal V; Robledo P; Galeote L; Bilkei-Gorzo A; Zimmer A; Maldonado R
J Neurosci; 2005 Feb; 25(5):1103-12. PubMed ID: 15689546
[TBL] [Abstract][Full Text] [Related]
3. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.
Castañé A; Valjent E; Ledent C; Parmentier M; Maldonado R; Valverde O
Neuropharmacology; 2002 Oct; 43(5):857-67. PubMed ID: 12384171
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of nicotine-induced rewarding effects in A2A knockout mice.
Castañé A; Soria G; Ledent C; Maldonado R; Valverde O
Neuropharmacology; 2006 Sep; 51(3):631-40. PubMed ID: 16793068
[TBL] [Abstract][Full Text] [Related]
5. Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin.
Trigo JM; Zimmer A; Maldonado R
Neuropharmacology; 2009 Jun; 56(8):1147-53. PubMed ID: 19376143
[TBL] [Abstract][Full Text] [Related]
6. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
Yamada H; Bishnoi M; Keijzers KF; van Tuijl IA; Small E; Shah HP; Bauzo RM; Kobeissy FH; Sabarinath SN; Derendorf H; Bruijnzeel AW
Pharmacol Biochem Behav; 2010 Jun; 95(4):401-9. PubMed ID: 20211642
[TBL] [Abstract][Full Text] [Related]
7. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens.
Schmidt BL; Tambeli CH; Gear RW; Levine JD
Neuroscience; 2001; 106(1):129-36. PubMed ID: 11564423
[TBL] [Abstract][Full Text] [Related]
8. Acute behavioural responses to nicotine and nicotine withdrawal syndrome are modified in GABA(B1) knockout mice.
Varani AP; Moutinho LM; Bettler B; Balerio GN
Neuropharmacology; 2012 Oct; 63(5):863-72. PubMed ID: 22727822
[TBL] [Abstract][Full Text] [Related]
9. The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.
Ignatowska-Jankowska BM; Muldoon PP; Lichtman AH; Damaj MI
Psychopharmacology (Berl); 2013 Oct; 229(4):591-601. PubMed ID: 23652588
[TBL] [Abstract][Full Text] [Related]
10. Mu-opioid receptors are involved in the tolerance to nicotine antinociception.
Galeote L; Kieffer BL; Maldonado R; Berrendero F
J Neurochem; 2006 Apr; 97(2):416-23. PubMed ID: 16539669
[TBL] [Abstract][Full Text] [Related]
11. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice.
Biała G; Budzyńska B; Kruk M
Pharmacol Rep; 2005; 57(6):755-60. PubMed ID: 16382193
[TBL] [Abstract][Full Text] [Related]
12. Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice.
Hutcheson DM; Matthes HW; Valjent E; Sánchez-Blázquez P; Rodríguez-Díaz M; Garzón J; Kieffer BL; Maldonado R
Eur J Neurosci; 2001 Jan; 13(1):153-61. PubMed ID: 11135013
[TBL] [Abstract][Full Text] [Related]
13. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
Ise Y; Narita M; Nagase H; Suzuki T
Psychopharmacology (Berl); 2000 Jul; 151(1):49-54. PubMed ID: 10958116
[TBL] [Abstract][Full Text] [Related]
14. Influence of δ-opioid receptors in the behavioral effects of nicotine.
Berrendero F; Plaza-Zabala A; Galeote L; Flores Á; Bura SA; Kieffer BL; Maldonado R
Neuropsychopharmacology; 2012 Sep; 37(10):2332-44. PubMed ID: 22669166
[TBL] [Abstract][Full Text] [Related]
15. The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors.
Robledo P; Mendizabal V; Ortuño J; de la Torre R; Kieffer BL; Maldonado R
Eur J Neurosci; 2004 Aug; 20(3):853-8. PubMed ID: 15255997
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
17. Mu opioid receptor-dependent and independent components in effects of tramadol.
Ide S; Minami M; Ishihara K; Uhl GR; Sora I; Ikeda K
Neuropharmacology; 2006 Sep; 51(3):651-8. PubMed ID: 16793069
[TBL] [Abstract][Full Text] [Related]
18. mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion.
Hall FS; Goeb M; Li XF; Sora I; Uhl GR
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):123-30. PubMed ID: 14969743
[TBL] [Abstract][Full Text] [Related]
19. Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.
Jackson KJ; Carroll FI; Negus SS; Damaj MI
Psychopharmacology (Berl); 2010 Jun; 210(2):285-94. PubMed ID: 20232057
[TBL] [Abstract][Full Text] [Related]
20. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
Biala G; Staniak N; Budzynska B
Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):361-70. PubMed ID: 20217050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
